eFFECTOR Therapeutics (EFTR) Financials

$0.00

$0.00 (0.00%)

As on 03-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.16	--	3.55	1.43	42.00	--
Cost of Revenue	0.11	0.11	0.05	0.02	0.16	0.31
Gross Profit	0.05	-0.11	3.50	1.43	42.00	-0.31
Operating Expenses	32.67	33.84	32.40	31.90	26.18	28.30
Operating Profit (EBIT)	-33.15	-33.84	-32.40	-31.90	15.82	-28.61
Other Income	--	--	--	49.46	--	--
Profit before Tax	-34.63	-35.81	-22.67	15.80	14.56	-29.74
Provision for Tax	-0.02	--	-9.74	-0.02	0.35	0.14
Profit after Tax (Net Income)	-34.63	-35.81	-12.93	15.80	14.21	-29.74
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-8.36	--	-22.67	15.80	0.17	-14.21

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	0.83	-5.80	3.90	17.28	0.98	-13.84
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.74	0.54	0.11	32.79	140.17	--
Current Liabilities	25.57	25.80	25.08	3.98	8.78	18.93
Total Liabilities	52.70	20.54	29.08	54.06	16.70	5.10

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.88	0.71	1.06	1.16	0.13	0.82
Current Assets	26.25	19.84	28.01	52.90	16.58	4.27
Total Assets	52.70	20.54	29.08	54.06	16.70	5.10
Total Debt*	20.25	20.55	20.28	20.03	12.96	15.25
Net Current Assets	0.68	-5.96	2.94	48.92	7.80	--

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-29.55	-25.90	-24.89	13.84	-27.60
Cash Flow from Investing Activities	--	14.48	-17.86	0.57	-0.15	0.08
Cash from Financing Activities	--	21.23	2.77	58.81	-1.89	20.24
Net Cash Inflow / Outflow	--	--	--	34.49	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-14.46	-13.41	-7.77	9.78	23.74	--
Cash EPS ($)	--	-13.37	-7.74	9.79	24.01	--
Adjusted Book Value ($)	--	--	2.34	10.70	1.64	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-11.07	-15.57	-15.40	23.11	--
Free Cash Flow per Share ($)	--	-11.10	-15.69	-15.43	22.85	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-183.99	-42.05	61.65	185.21	--
ROE (%)	--	3,771.56	-122.07	173.01	-221.01	--
ROA (%)	-68.38	-144.34	-31.10	44.65	130.38	--
EBIT Margin (%)	-19,724.69	--	-911.99	-2,230.56	37.85	--
Net Margin (%)	-21,376.54	--	-363.83	31.04	33.84	--
Cash Profit Margin (%)	-0.19	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-95.44	-1.00	1.48	-0.97	--	--
EBIT Growth (%)	4.00	-1.51	-1.59	-300.67	156.05	--
Net Profit Growth (%)	3.13	-177.02	-181.83	11.17	147.79	--
EPS Growth (%)	32.86	-0.73	-1.79	-0.59	--	--
Book Value Growth (%)	110.81	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.03	-0.06	0.85	--	--
Price / Book Value	0.00	-0.22	0.18	0.77	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.41	-0.10	0.16	0.51	--	--
Close Price ($)	14.39	11.68	10.69	207.00	--	--
High Price ($)	275.00	37.00	224.75	1,010.50	--	--
Low Price ($)	8.45	8.45	9.00	137.50	--	--
Market Cap ($ Cr)	0.00	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-3.55	5.21	1.16	13.24	-1.10
Short term debt to equity ratio	24.27	-3.55	5.19	0.00	6.14	-1.10
Current Ratio	1.03	0.77	1.12	13.30	1.89	0.23
Quick Ratio	1.03	--	1.12	13.32	--	--
Interest Coverage	-10.62	-11.27	-14.39	-18.08	11.92	-20.53

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	10.49	--	0.76	6.99	--	--
Asset Turnover	0.00	--	0.09	0.04	3.85	--
Receivable days	--	--	6.53	25.54	--	--
Inventory Days	--	-88.84	-437.61	-1,521.88	--	--
Payable days	--	6,278.35	6,898.40	6,566.89	1,078.63	711.46
Cash Conversion Cycle	--	--	-7,329.48	-8,063.22	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.